Cliff Ding

Cliff Ding has extensive work experience in the field of biostatistics and data management. Cliff currently holds the position of Vice President, Clinical Data Science at Tessa Therapeutics Ltd since February 2020. Prior to that, they served as Vice President, Biostatistics, Subject Matter Expert at PAREXEL International from October 2019 to February 2020. Cliff also worked as Senior Director, Biostatistics and Data Management at Jounce Therapeutics, Inc. from June 2019 to October 2019. Cliff Ding held the position of Executive Director, Biostatistics and Data Management at Symphogen for three years, from March 2016 to June 2019. Cliff served as Senior Director, Biostatistics & Data Management at Taiho Oncology Inc from March 2013 to March 2016. Further, they held the position of Senior Director, Biostatistics and Data Management at Enzon Pharmaceuticals for seven years, from January 2006 to February 2013. Cliff Ding also worked as Director, Biostatistics at Eli Lilly and Company (ImClone Systems) from November 2004 to January 2006. Additionally, they held the position of Director, Biostatistics and Data Management at Immunomedics from July 2003 to November 2004. Cliff Ding worked as an Associate Director, Biostatistics at Pfizer (legacy Pharmacia) from February 2002 to July 2003. Cliff began their career as an Assistant Director, Biostatistics at Johnson & Johnson (Jansen Research Foundation) in May 1994, where they worked for eight years until February 2002.

In summary, Cliff Ding has over 25 years of experience in various biostatistics and data management roles, with a focus in the pharmaceutical industry.

Cliff Ding completed their Bachelor of Science degree in Mathematics from Peking University from 1980 to 1984. Cliff then pursued a Ph.D. in Statistics at the University of Kentucky, graduating in 1994.